General MedicationsORALStandard
ONUREG
AZACITIDINE
Standard Dose
200MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Prescription
Summary
Approval overview ONUREG is listed in Drugs@FDA under application 214120 (NDA).
Review priority: N/A Marketing status: Prescription Active ingredient AZACITIDINE Form and strength TABLET;ORAL - 200MG Sponsor BRISTOL Submission history Latest submission status date: 2021-05-17 00:00:00.
Structured Monograph
Clinical summary
Approval overview ONUREG is listed in Drugs@FDA under application 214120 (NDA). Review priority: N/A Marketing status: Prescription Active ingredient AZACITIDINE Form and strength TABLET;ORAL - 200MG Sponsor BRISTOL Submission history Latest submission status date: 2021-05-17 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: N/A
Interaction Notes
- No interaction notes stored yet.